News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 02 nov 2023 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 02 ago 2023 Neuchâtel: the new Swiss crypto haven At the heart of Western Switzerland, a revolution is quietly brewing. Where most would expect the bustling financial hubs of Geneva or Zug to spe...
News 31 mar 2022 Investment projects reach pre-COVID level The Greater Zurich Area attracted 125 new companies to its nine cantons in 2021. They are planning to create more than 1,800 new jobs in sectors ...
News 30 set 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News 13 abr 2021 Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp Biopharmaceutical giant Lonza has announced the creation of 1,200 new jobs for the manufacturing of Moderna’s Covid-19 vaccine on its site in Vis...
Global Opportunities 03 jun 2020 The Pharmaceutical Sector in Ireland: Opportunities for Swiss companies As cornerstones of the Irish economy, the pharma and life sciences sectors have contributed vastly to the attractiveness of Ireland to foreign co...
Инвестиции в Швейцарии Ваши контакты за рубежом Представительства S-GE за рубежом называются «Швейцарские Центры содействия бизнесу» (Swiss Business Hubs).
Globales Netzwerk Unsere Standorte weltweit Gemeinsam mit dem Eidgenössischen Departement für auswärtige Angelegenheiten (EDA) unterhalten wir derzeit Vertretungen in mehr als 25 ...
Réseau Mondial Nos antennes dans le monde En collaboration avec le Département fédéral des affaires étrangères (DFAE), nous entretenons actuellement des bureaux dans plus de 25 pays.
News 18 dez 2017 New conformity assessment procedure in the United Arab Emirates The new conformity assessment covers restrictions on the use of hazardous ingredients in electronic and electrical goods (RoHS: Restriction of Ha...